Navigation Links
US Army plans to bulk-buy anthrax

The US military wants to buy large quantities of anthrax, in a controversial move that is likely to raise questions over its commitment to treaties designed to limit the spread of biological weapons.

A series of contracts have been uncovered that relate to the US army' Dugway Proving Ground in Utah. They ask companies to tender for the production of bulk quantities of a non-virulent strain of anthrax, and for equipment to produce significant volumes of other biological agents. Issued earlier this year, the contracts were discovered by Edward Hammond, director of the Sunshine Project, a US-German organisation that campaigns against the use of biological and chemical weapons.

One "biological services" contract specifies: "The company must have the ability and be willing to grow Bacillus anthracis Sterne strain at 1500-litre quantities." Other contracts are for fermentation equipment for producing 3000-litre batches of an unspecified biological agent, and sheep carcasses to test the efficiency of an incinerator for the disposal of infected livestock.

Although the Sterne strain is not thought to be harmful to humans and is used for vaccination, the contracts have caused major concern. "It raises a serious question over how the US is going to demonstrate its compliance with obligations under the Biological Weapons Convention if it brings these tanks online," saysAlan Pearson, programme director for biological and chemical weapons at the Center for Arms Control and Non-Proliferation in Washington DC. "If one can grow the Sterne strain in these units, one could also grow theAmes strain, which is quite lethal." The US renounced biological weapons in 1969, but small quantities of lethal anthrax were still being produced at Dugway as recently as 1998.

It is not known what use the biological agents will be put to. They could be used to test procedures to decontaminate vehicles or buildings, or to test an "agent defeat" warhead designed to destro y stores of chemical and biological weapons. There are even fears that they could be used to determine how effectively anthrax is dispersed when released from bombs or crop-spraying aircraft. "I can definitely see them testing biological weapons delivery systems for threat assessment," says Hammond.

Whatever use it is put to, however, the move could be seen as highly provocative by other nations, he says. "What would happen to the Biological Weapons Convention if other countries followed suit and built large biological production facilities at secretive military bases known for weapons testing?"

A spokesperson for Dugway said the anthrax contract is still at the pre-solicitation stage, and the base has not yet acquired the agent. They refused to say what it will be used for.


Source:New Scientist

Related biology news :

1. Woods Hole Research Center plans controlled burn in Amazon rainforest
2. Anemone genes reveal versatile building blocks for body plans
3. Antibodies from plants protect against anthrax
4. New antibody shows promise as cure for anthrax
5. Vaccine combined with short-term postexposure antibiotics protects monkeys from inhalational anthrax
Post Your Comments:

(Date:10/29/2015)... RESTON, Va. , Oct. 29, 2015 ... announced today that it has released a new version ... Daon customers in North America ... gains. IdentityX v4.0 also includes a FIDO UAF ... customers are already preparing to activate FIDO features. These ...
(Date:10/29/2015)... Connecticut , October 29, 2015 ... a biometric authentication company focused on the growing ... smart wallet announces that StackCommerce, a leading marketplace ... be featuring the Wocket® smart wallet on StackSocial ... NXTD ) ("NXT-ID" or the "Company"), a biometric ...
(Date:10/27/2015)... Germany , October 27, 2015 ... SMI,s Automated Semantic Gaze Mapping technology (ASGM) automatically maps ... SMI,s Eye Tracking Glasses , so that they ... BeGaze. --> Munich, Germany , ... (ASGM) automatically maps data from mobile eye tracking videos ...
Breaking Biology News(10 mins):
(Date:11/24/2015)... Nov. 24, 2015 HemoShear Therapeutics, LLC, ... drugs for metabolic disorders, announced today the appointment ... Board of Directors (BOD). Mr. Watkins is the ... Genome Sciences (HGS), and also served as the ... Jim Powers , Chairman and CEO of HemoShear ...
(Date:11/24/2015)... MUNICH and NEW YORK , ... irst investment by Bristol-Myers Squibb in a ... Bristol-Myers Squibb Company in which the companies ... products in immuno-oncology and other areas of unmet medical need. ... Squibb in LSP 5, the latest LSP fund. This is ...
(Date:11/24/2015)... Nov. 24, 2015 According to two new studies, ... This is something that many doctors, scientists, and public health ... remains: with fewer PSA tests being done, will there be ... Dr. David Samadi, "Despite the efforts made in ... the second leading cancer cause of death in men, killing ...
(Date:11/23/2015)... --  Ceres, Inc . (Nasdaq: CERE ), an ... fiscal year ended August 31, 2015 and provided an ... --> During fiscal year 2015, Ceres refocused ... a better balance of yield, energy and nutrition. Among ... leading crop input providers and made significant progress in ...
Breaking Biology Technology: